InvestorsHub Logo
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

Re: DanWebzster post# 182

Friday, 06/01/2018 10:47:15 AM

Friday, June 01, 2018 10:47:15 AM

Post# of 438
ONCS hired former AVXS CEO Daniel OConnor. How responsible was he for AVXS technological innovation? I don't know.

ONCS technology involves localized injection of a cytokine into tumor followed by the delivery of electrical pules

Preliminary data in the combo therapy with Keytruda will be presented in 2018.

Breakthrough Therapy & Fast Track Designations are possibilities.

2/28/18, Cash = $37.6mn giving them a runway into Q4/2018.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.